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patients suffering from type 1 diabetes mellitus. Pancreata are frequently not accepted for transplantation, because of the relatively
high vulnerability of these organs to ischemic injury. In this study, we evaluated the effects of hypothermic machine perfusion (HMP)
on the quality of human pancreas grafts. Methods. Five pancreata derived from donation after circulatory death (DCD) and 5
from donation after brain death (DBD) donors were preserved by oxygenated HMP. Hypothermic machine perfusion was per-
formed for 6 hours at 25mmHg by separate perfusion of the mesenteric superior artery and the splenic artery. Results were com-
pared with those of 10 pancreata preserved by static cold storage. Results. During HMP, homogeneous perfusion of the
pancreas could be achieved. Adenosine 5′-triphosphate concentration increased 6,8-fold in DCD and 2,6-fold in DBD pancreata.
No signs of cellular injury, edema or formation of reactive oxygen species were observed. Islets of Langerhans with good viability
and in vitro function could be isolated after HMP.Conclusions.Oxygenated HMP is a feasible and safe preservation method for
the human pancreas that increases tissue viability.
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Transplantation DIRECT ■ 2018pancreatic beta cells.1 Patients with uncomplicated type 1 di-
abetes mellitus are usually treated with insulin injections. In a
selected group of patients, replacement of functioning beta
cells by whole pancreas transplantation (PT) or islet trans-
plantation (IT) is the treatment of choice.1-3 Results of PT
have significantly improved over the last decade, mainly
due to better surgical techniques and improved immunosup-
pressive strategies.4 Pancreas transplantation is, however, a
complex procedure with considerable perioperative morbid-
ity and mortality, requiring a strict recipient screening. In
contrast, IT is technically less complex and has lower mor-
bidity. However, because of the exposure of islets to multiple
series of physiochemical stress factors during isolation and
immediate blood-mediated inflammatory reaction during
transplantation, there is considerable islet loss requiring
often 2 and sometimes 3 donor pancreata per recipient to
achieve insulin independence.5 Islet transplantation has the
potential to stabilize blood glucose levels, stop hypoglycemic
unawareness and may contribute to the prevention of dia-
betic sequelae.2,6
Despite the encouraging results, pancreas and IT are less
often performed compared to kidney and liver transplanta-
tion.3 A key factor is the shortage of good quality pancreas
grafts. Compared to other organs, the pancreas is more vul-
nerable to injury related to brain death and the actual organ
retrieval operation.7 Also, in contrast to transplantation of
other organs, beta cell replacement is not an immediate life-
saving procedure, and therefore, centers tend to take lower
risks with regard to the quality of the donor organ when
accepting the pancreas.3 Due to donor organ shortage many
centers will now accept organs from older and higher-riskwww.transplantationdirect.com 1
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death (DBD) donors and from donation after circulatory
death (DCD) donors. Donation after circulatory death dona-
tion for islet isolation is still uncommon.8,9 Andres et al
showed that DCD pancreata gave similar islet yield and clin-
ical outcomes asDBDpancreata.However, acceptable factors
for acceptation of DCD pancreata remain to be defined.10
Donation after circulatory death pancreata are thought to
be inferior because the warm ischemia period and more pro-
nounced ischemia-reperfusion injury leads to a significant de-
pletion of adenosine 5′-triphosphate (ATP) and accumulation
of toxic metabolites.3,11 The current challenge is to increase
the donor pool by utilization of these extended criteria donor
pancreata without compromising transplantation outcomes.
One method to achieve this is by improvement of pancreas
preservation techniques. Currently, static cold storage (SCS)
is the standard preservation method for the pancreas. A plau-
sible alternative is hypothermic machine perfusion (HMP),
providing a continuous arteriovenous circulation of a dedi-
cated preservation solution. In kidney transplantation, clinical
trials and registry data have demonstrated superiority of
HMP over SCS, while in liver transplantation there is now evi-
dence that HMP may enhance the quality of higher-risk livers
before transplantation.12-17 It is suggested that the positive effect
ofHMP is due to the continuous perfusion of themicrovascular
system, resuscitating ATP levels in the tissue and removing toxic
waste products.9,12,18-20 While effective for kidneys and livers,
the impact of HMP on enhancing human pancreas quality, by
reducing reperfusion injury has remained unexplored.
In this study, we evaluated the feasibility of oxygenated
HMP in discarded human donor pancreata. We developed
a customized dual arterial system, allowing separate perfu-
sion of both main arteries supplying the pancreas graft. Via-
bility and injury markers were analyzed and compared with
those of SCS preserved pancreata. Both DCD and DBD do-
nor pancreata were included to analyze preservation effects
in both groups.FIGURE 1. Schematic overview of the injurious periods in the
pancreata as reflected by color intensity in the 4 different groups.MATERIALS AND METHODS
Donor Pancreata
Between May 2013 and May 2015, 20 human pancreata
retrieved from multiorgan donors in The Netherlands were
included in this study. The pancreata were declined for pan-
creas and islet transplantation and permission for research
was given by the relatives of the donor. This study was ap-
proved by the medical ethical committee of the University
Medical Center Groningen and the Dutch Transplantation
Foundation as the competent authority for Organ Donation
in the Netherlands. The pancreata were retrieved by regional
multiorgan recovery teams according to standard methods.
Just before stapling the duodenum, 50 mL of povidione io-
dine was administered via the nasogastric tube. All pancreata
were stored in University ofWisconsin Cold Storage Solution
(Bridge to Life, London, United Kingdom).
Experimental Design
After a period of SCS during transportation to the study
center, pancreata were assigned to 2 preservation groups. The
experimental group underwent 6 hours of HMP (n = 10),
the control group underwent an additional 6 hours of SCS
(n = 10). In both groups, 5 DCD and 5 DBD pancreata wereincluded (Figure 1). Characteristics of the donor pancreata
and ischemia times are shown in Table 1. No significant dif-
ferences were observed in donor age, body mass index, do-
nor serum amylase and lactate dehydrogenase (LDH),
warm ischemia time (WIT), back table procedure time and
total cold ischemia time (CIT).
Back Table Procedure
After the pancreata arrived at the study center, a back table
procedure was performed, which included tissue biopsies,
splenectomy and ligation of the gastroduodenal artery. The
pancreata in the experimental group were prepared to be
connected to the HMP device: the superior mesenteric artery
(SMA) and splenic artery (SA) were cannulated by using a
hose barb with a luer lock end, connecting a cannula. The ar-
tery was secured to the hose barb with a cable tie. The portal
vein was left open to ensure passive drainage of perfusion
fluid. The pancreas was placed in a pancreas chamber of the
device, partly submerged in cold University of Wisconsin
Machine Perfusion Solution (Bridge to Life, London, United
Kingdom). The arteries were flushed with perfusion solution
using a syringe to detect leaks of small vessels, which were
corrected using vascular clips.
The HMP device consisted of a dual perfusion system
using a pressure controlled recirculation circuit, with 2 cen-
trifugal pumps (Deltastream DPII; MEDOS Medizintechnik
AG, Stolberg, Germany) providing a pulsatile flow through
themesenteric and splenic arteries, separately. Perfusion pres-
sure was set at 25 mmHg in both systems. The perfusion so-
lution (1 L) was oxygenated by 2 hollow fiber oxygenators
(HILITE 800 LT; MEDOS Medizintechnik AG) with a fixed
oxygen flow of 100 mL/min. The temperature of the perfu-
sion solution was kept between 4°C and 7°C by placement
of the system in a cool box filled with ice. To measure perfu-
sion efficacy, Acridin Orange (AO, 0.1 mg/L) was added to
the perfusion solution in 6 out of 10 HMP preserved
pancreata. When duodenal distention occurred, a duodenal
drain was needed. Figure 2 shows the setup of the HMP de-
vice. Because the machine is running on batteries, HMP
could be performed during transport.
Data Collection
Baseline wedge biopsies (0.5 cm3) were taken from all
pancreata: 2 from the head, 1 from the body and 1 from
TABLE 1.
Donor characteristics
HMP DCD (n=5) HMP DBD (n=5) SCS DCD (n=5) SCS DBD (n=5) P
Male, % 80 80 100 40
Age, y 58 (51-64) 71 (53.5-73.5) 50 (20.5-63.5) 60 (51.5-67) 0.271
BMI, kg/m2 23 (20.5-30) 26 (2.5-29) 27 (25-28.5) 29 (26.5-32) 0.259
Donor serum LDH, U/L 226 (188-182) 346 (180-510) 480 (199-480) 241 (230-440) 0.617
Donor serum amylase, U/L 88 (26-88) 121 (21-300) 47 (22-125) 106 (38-270) 0.673
WIT, min 18 (14-20) - 21 (15-24.5) - 0.292
CIT1, min 236 (219-268) 183 (143-299) 227 (212-228) 292 (250-300) 0.297
Back table procedure 60 (60-60) 90 (60-90) 30 (30-60) 30 (30-35) 0.262
CITtot, min 596 (579-628) 543 (503-659) 587 (572-588) 652 (610-660) 0.297
BMI, body mass index; CIT1, CIT (start cold perfusion at donor hospital - start back table procedure in study center); CITtot, total CIT (start perfusion at donor hospital - end of experiment). Results are shown as
median and IQR.
© 2018 Wolters Kluwer Leemkuil et al 3the tail. These biopsies were snap frozen in liquid nitrogen
and stored at −80°C for fluorescence microscopy, wet/dry ra-
tio and measurement of ATP concentration. Another 2 biop-
sies were taken (head and tail) and fixed in 4% formaldehyde
for histological analysis.
In the experimental group, perfusion flow was measured
after 5, 10, 15, 20, and 30minutes ofHMP, followed bymea-
surements every 30 minutes. Perfusion fluid temperature was
recorded every hour. Samples (1 mL) of the perfusion solu-
tion were collected at 60-minute intervals during machine
perfusion and before and after SCS in the control group.
These samples were stored at −20°C for determination of en-
zyme levels, using standard biochemical assays. Another
sample (200 μL) was taken every hour, snap frozen in liquid
nitrogen and stored at −80°C for analysis of thiobarbituric
acid reactive substances (TBARS) concentration, reflecting
reactive oxygen species activity.
Markers of Viability and Injury
ATP concentration was analyzed by using the ATP Bio-
luminescence assay kit CLS II (Roche Diagnostics GmbH,
Boehringer Mannheim, Germany). ATP and TBARS mea-
surements were performed as described earlier by our
laboratory.21
Wet-to-dry weight ratio of the tissue was measured as an
indicator of edema. The weight of the biopsy was measured
before (wet weight) and after (dry weight) the biopsy was
dried in a heat block (VWR international, Leuven, Belgium)
at 95° for 24 hours.
Histological Analysis
Cryosections (4 μm) of pancreas tissue were examined with
a fluorescence microscope (Leica, Rijswijk, The Netherlands)FIGURE 2. Dual arterial perfusion setup. 1, rotary pump; 2, oxygen-
ator; 3, pressure sensor; 4, flow sensor; 5, temperature sensor.with 495/519 nm filter for direct observation of the AO stain-
ing. Biopsies were fixed in 4% formaldehyde, subsequently
embedded in paraffin and cut into sections of 4 μm. Light mi-
croscopy of hematoxylin and eosin–stained sections was per-
formed to evaluate changes in morphology. No validated
scoring system for histological analysis of donor pancreata ex-
ists, so a scoring system was developed, partly based on previ-
ous work by Karcz et al.7 Morphometry was performed on
the sections, assessing changes in 3 parameters: edema, acinar
cell integrity loss and vacuolization. Each parameter was
scored using the following semiquantitative scale: grade 0
(not affected), grade 1 (moderately affected) and grade 2 (se-
verely affected). Caspase-3 staining (Cell Signaling, Asp175,
Rabbit, 1:100) was performed to evaluate the extent of apo-
ptosis. All slides were scored in a semiquantitative scale: the
percentage islets scoring grade 0 (no caspase-3 staining), grade
1 (<50%of the islet stained positive for caspase-3) and grade 2
(≥50% of the islet stained positive for caspase-3). Examples
of histological analysis are shown in Figures S1 and S2,
http://links.lww.com/TXD/A138. The results were analyzed
using the H-score of these grades. All sections were analyzed
in a blinded fashion by 2 investigators (ML and GL) and con-
firmed by a blinded pathologist (NtH).
Islet Isolation Procedure
Two pancreata preserved by HMP were used for an islet
isolation procedure at the human islet isolation laboratory
(GMP facility) of the Leiden UniversityMedical Center as de-
scribed previously.22-24 During transportation to Leiden, the
pancreata continued to be perfused in the HMP device. Islet
isolation started directly after arrival at the isolation labora-
tory. Perfusion time and total CIT did not differ from the
other pancreata. After termination of HMP, the organ was
surgically prepared; the pancreatic duct was cannulated with
a cannula, after which the organwas perfused at 4°C to 10°C
with collagenase NB1 and neutral protease (Serva Electro-
pheresis, Germany), aiming formild pancreas distensionwith
minimal enzyme leakage. After distension, the pancreas was
digested in a closed loop at 37°C, during which the released
pancreatic tissue was collected and washed. Subsequently
the islets were purified using density gradient separation in
a COBE 2991 Cell separator (Terumo BCT, Lakewood,
CO). Finally, the islets were cultured in CMRL-1066 solution
(Corning-Mediatech, Manassas, VA) supplemented with
10% ABO-compatible human serum (Sanquin Bloodbank,
The Netherlands) until they were assessed for quality. Islet
4 Transplantation DIRECT ■ 2018 www.transplantationdirect.comequivalent (IEQ) was calculated after assessment of purity
and pellet volume of the islet product.23 The number of iso-
lated islets (expressed in IEQ and IEQ/g) as well as islet viabil-
ity was tested.25 In addition, islet preparationswere subjected
a static glucose-stimulated insulin secretion test performed at
a low glucose concentration of 1.67 mmol/L and a high glu-
cose concentration of 16.7 mmol/L. Briefly, pancreatic islets
(n = 20) were subsequently incubated in Krebs buffers con-
taining 1% human serum albumin and with a low or a high
(45 minutes each) glucose concentration. From these incuba-
tions samples were taken and the concentration of secreted
human insulin was determined by ELISA (Mercodia, Uppsala,
Sweden). The stimulation indexwas calculated as (insulin con-
centration at 16.7 mM glucose) / (insulin concentration at
1,67 mM glucose).
Statistical Analysis
Continuous datawere presented asmedian and interquartile
range (IQR). For statistical analysis of independent samples,
Mann Whitney U tests were performed. For paired samples,
Wilcoxon signed-rank tests were performed. Kruskal-Wallis
tests were performed to analyze data of >2 groups. Categorical
variableswere compared using the Fischer exact test. Results of
the HMP and SCS preserved pancreata were compared in
DCD and DBD pancreata separately. The level of significance
was set at P less than 0.05. IBM SPSS Statistics version 23 for
Windows was used.
RESULTS
HMP of the Human Pancreas Is Technically Feasible
In the DCD group, perfusion flow in the SMAwas higher
than in the SA during the first minutes of HMP (P < 0.05).
Flow in the SA increased during HMP and became similar
to flow in the SMA. After 360 minutes, median flow in both
arteries was 36 mL/min. In the DBD group, flow increased
nonsignificantly in both arteries and stabilized after 4 hours
of HMP to 52 mL/min and 38.5 mL/min in the SMA and
SA, respectively (Figure 3). There was no significant differ-
ence in flow between the DCD and DBD group. In the
6 pancreata where AO was added to the perfusion solution,
AO staining was visible in all biopsies throughout the pan-
creas, demonstrating uniform perfusion (Figure 4). Median
temperature of the perfusion fluid during HMP varied be-
tween 5.5°C and 7.0°C.
In 7 of 10 pancreata a duodenal drain was placed. In DCD
pancreata 80 mL (IQR, 0-98 mL) and in DBD pancreata
70 mL (IQR, 40-120 mL) of fluid passively drained, which
was a combination of duodenal content, povidione iodide
and perfusion fluid.
Maintenance of Tissue Integrity
No significant differences were seen in edema formation,
acinar cell integrity loss or vacuolization between HMP and
SCS in both DBD and DCD pancreata. In both DCD and
DBD pancreata, wet/dry ratio did not change after preserva-
tion andwas equal in both theHMPand SCS group (Figure 5).
HMP Provides Increased Viability of the Pancreatic
Tissue Without Signs of Injury
ATP concentration in the tissue is shown in Figure 6. At ar-
rival in our hospital, ATP concentration in DCD pancreata
was 8.4 (IQR, 3.0-15.6) μmol/g protein. ATP concentrationin DBD pancreata at this moment was significantly higher:
48.2 (IQR, 29.5-67.3) μmol/g protein (P = 0.003). After
prolonged SCS, ATP concentration decreased further to
2.9 (IQR, 2.8-5.7) μmol/g protein in DCD pancreata and
22.8 (IQR, 20.6-46) μmol/g protein in DBD pancreata
(P < 0.05). In contrast, after HMP ATP concentration in
both DCD and DBD pancreata increased significantly
(P < 0.05). In the DCD group a 6.8-fold increase and in
the DBD group a 2.6-fold increase was observed. Interest-
ingly, ATP concentration in DCD pancreata reached the
same level of DBD pancreata: 100.5 (IQR, 49.4-169.8) and
109.3 (IQR, 65.2-301.5) μmol/g protein in DCD and DBD
pancreata, respectively. In our laboratory using the same ATP as-
say, ATP level in normothermic sham livers was found to be
around 60 μmol/g protein.26
Thiobarbituric acid reactive substance concentration in
the preservation fluid was determined to analyze the for-
mation reactive oxygen species. In all samples TBARS con-
centration remained low and almost nondetectable. No
significant differences were seen between HMP and SCS
preserved pancreata (data not shown). To evaluate the extent
of apoptosis in the tissue, caspase-3 staining was performed.
Only islets of Langerhans showed a positive caspase-3 stain-
ing, with no staining in the exocrine tissue of the same
pancreata. No significant differences in caspase-3 staining
were observed before and after HMP/prolonged SCS or be-
tween DBD and DCD pancreata.
Pancreatic Enzyme Levels
Amylase and lipase concentration in the perfusion solution
increased significantly after 6 hours of HMP, as well as after
6 hours of SCS (P < 0.05). Amylase increased significantly
during the entire period of HMP. Lipase increased predom-
inantly during the first 3 hours of HMP after which a pla-
teau was reached. The absolute increase in amylase and
lipase was significantly higher after HMP compared to SCS
in DCD pancreata (Figure 7A-D). No significant difference
in absolute amylase and lipase increase between the 2
preservation methods was observed in DBD pancreata.
Lactate dehydrogenase concentration in the perfusate
was measured as a marker for cellular damage. Lactate
dehydrogenase increased significantly after HMP as well
as SCS (P < 0.05). The absolute increase in LDH after
6 hours of preservation did not differ between the groups
(Figure 7E, F).
Islet Isolation (n = 2)
Islets were isolated from 2HMP preserved DCD pancreata,
retrieved from a 50- and a 52-year old donor (both males).
Islet yield was 378.261 (3999 IEQ/g tissue) and 400.000
(6452 IEQ/g tissue) respectively. Viability was 94 and 98%
after isolation and 90 and 92% after 3 days in culture. The
insulin stimulation index was 2.2 and 1.9, respectively.DISCUSSION
This is the first report describing a dual arterial hypother-
mic perfusion system for preservation of the human donor
pancreas. With our system, uniform perfusion of the pan-
creas was achieved, without edema formation or tissue injury
in hypothermic conditions. A substantial increase in ATP
concentration was seen, indicating an improved viability af-
ter HMP. Viable and functioning islets could be isolated.
FIGURE 3. Perfusion flow during HMP. A, In DCD pancreata, perfusion flow in the SMAwas significantly higher than in the SA in the first 5 mi-
nutes of HMP (P < 0.05). After 6 hours, median flow in both arteries was equal. B, In DBD pancreata, flow in both arteries showed a nonsig-
nificant increase during HMP. Flow in both arteries did not differ during 6 hours of HMP. SA, represented by circles, SMA, represented by
squares. Results are shown as median and IQR.
FIGURE 4. AO fluorescent staining after 6 hours of HMP. Scale bar
indicates 75 μm. Dotted line indicates one of the pancreas lobuli.
© 2018 Wolters Kluwer Leemkuil et al 5In this study, 20 human pancreata were preserved for
6 hours either by HMP or prolonged SCS after an initial pe-
riod of SCS. The period of 6 hours was chosen to ensure a to-
tal cold preservation time of 9 to 11 hours, comparable to the
average CIT in clinical pancreas and IT.4 HMP was per-
formed at 25 mm Hg using a pressure controlled perfusion
system. In hypothermic conditions the pressure should be
low to prevent the organ from barotrauma. 't Hart et al
showed that 25%of the normal physiological pressure seems
optimal in hypothermic liver preservation.27,28 In pancreas
perfusion studies, various perfusion pressures were used,
ranging from 10 to 30 mmHg in canine, porcine and human
pancreata.7,29-32 In a pilot study on porcine pancreata, differ-
ent perfusion pressures were analyzed (10, 25, and 40mmHg).
Twenty-five mm Hg seemed optimal for complete perfusion
of the pancreas. In this study, perfusion flow stabilized after
an initial increase in the first hours of HMP, which was also
described earlier.7,33 The quality of perfusion was assessed
by fluorescent staining with AO in 6/10 pancreata. Staining
withAOwas visible in all these pancreata, indicating a complete
and uniform perfusion.
One of the concerns related to pancreas preservation is the
development of edema, which is generally regarded as unde-
sirable as it has been shown to correlate with a lower IEQ af-
ter isolation.11,34 In our study, no signs of edema formation
were observed after HMP. The impact of edema formation
due to HMP is however questionable since Taylor showed
in a porcine study that despite edema formation after
24 hours of HMP, a more uniform digestion of the pancreas
and thereby higher IEQ was realized.31
Histological analysis revealed neither loss of acinar cell in-
tegrity nor vacuolization which can be seen in apoptosis. This
corresponds with the results from the caspase-3 staining in
which both the DBD and DCD pancreata showed equal levels
of apoptosis before and after HMP or prolonged SCS. It
should however be acknowledged that these results might be
an underestimation since no normothermic reperfusion was
performed, which will lead to full expression of tissue injury.
In this study, the preservation fluid was oxygenated with
100% oxygen during HMP. There is no clear consensus
about the need for oxygen supply during HMP but many re-
searchers advocate the use of oxygen even in hypothermic
conditions.14-17 Hypothermia induces lowered metabolism
reducing the oxygen requirement of the tissue. Hence, at 4°
of Celsius the metabolism is 10% of normal.35 OxygenatedHMP is considered to support remaining metabolism and
prevent a further decline of cell energy levels. When metabo-
lism switches from an aerobic to anaerobic state, lactate and
hydrogen ions accumulate in the tissue, leading to acidosis.
This causes induction of lysosomal instability, activated en-
zymes, disrupted binding of transition ions to carrier proteins
and decreased mitochondrial function.2,35 A constant supply
of oxygen along with adenosine as a precursor for ATP for-
mation might result in increased ATP concentration during
preservation.14,36 Increased ATP concentration in pancreas
grafts is associated with better outcome after transplanta-
tion.2,37,38 Our results show that DCD pancreata are almost
ATP deplete in contrast to DBD pancreata. This is thought to
be the result of the period of warm ischemia, as has also been
shown for kidneys and livers.16,35,39 After HMP, a significant
increase in ATP was seen in both DCD and DBD pancreata.
After HMP, no difference in ATP concentration between
DCD and DBD pancreata is present anymore. This indicates
that especially the more injured DCD organs benefit more of
oxygenatedHMP, which is in line with studies in kidneys and
livers.14,16,35 We hypothesize that HMP has the potential to
improve viability of DCD pancreata toward DBD pancreata.
In our experiments, formation of TBARS could not be ob-
served, indicating that oxygenated HMP is a safe preserva-
tion method regarding to the formation of free oxygen
radicals as is also shown by other groups.36
FIGURE 5. Percentage of wet tissue per pancreas. A, In DCD pancreata, wet tissue content did not change at T1, no significant differences
between groupswere seen. B, In DBDpancreata, wet tissue content decreased after HMP, however no significant differenceswere seen between
groups. Closed colored figures represent HMP pancreata, open figures represent SCS pancreata. T0, before preservation; T1, after preservation.
6 Transplantation DIRECT ■ 2018 www.transplantationdirect.comDifferent amounts of duodenal drainage fluid were present
in the pancreata. Unfortunately, because of fluid consistency
and color, enzyme levels could not be measured reliably. Am-
ylase and lipase concentration in the preservation solution
increased significantly in both HMP and SCS preserved
pancreata. As no differences in acinar cell integrity
throughout the tissue was seen by histological analysis,
we assume that this is partly due to the injury induced by
taking multiple biopsies before preservation. This might lead
to leakage of enzymes in the preservation solution. However,
the absolute increase of amylase and lipase was significantly
higher after HMP compared to SCS in the DCD group, and
nonsignificantly higher in the DBD group. We hypothesize
that this can be ascribed to the constant flush during HMP.
The fact that LDH levels were the same in SCS and HMP pre-
served pancreata strengthens our hypothesis that the increased
amylase and lipase levels are not due to acinar cellular injury
during HMP.
Islet isolation was performed in 2 pancreata, to determine
the potential to use perfused pancreas for islet isolation. An
adequate amount of good quality islets could be isolated
from both pancreata. According to the IEQ, both isolation
procedures could be called an isolation success.40,41 Islets
were viable directly after isolation and after 3 days in cultureFIGURE 6. ATP concentration in the tissue before and after preservation
increased significantly after 6 hours of HMP (*P < 0,05). B, ATP in DBD
and increased significantly after 6 hours of HMP (#P < 0,05). Closed
SCS pancreata.with a normal in vitro function. This results are in line with
2 other studies in which islet isolation after a period of
HMP showed improved IEQ and viability compared to pro-
longed SCS.32,42
Limitations
The main limitation of this study is the lack of post-
transplant evaluation. To evaluate the effect of preservation
on the tissue in a more physiological environment, a normo-
thermic (37°C) reperfusion model could be used to mimic
transplantation. In this study we did not perform this kind
of reperfusion, so we have to be careful with our conclusions.
However, we were able to show that viable and functional is-
lets could be obtained from 2 pancreata after HMP. Although
numbers are small, we believe that more research into the use
of HMP in pancreata from extended donor criteria donors
for islet isolation is warranted.
CONCLUSIONS
In conclusion, this study demonstrates that oxygenated
HMP of the human pancreas is technically feasible. Uniform
perfusion of the pancreas was achieved and no signs of injury
were seen under hypothermic conditions. Viability improved
after HMP and functional isolated islets could be obtained.in DCD and DBD pancreata. A, ATP concentration in DCD pancreata
pancreata decreased significantly after 6 hours of SCS (*P < 0.05)
colored figures represent HMP pancreata, open figures represent
FIGURE 7. Enzyme concentration in perfusion fluid. A, B, Absolute amylase content in the perfusion fluid increased significantly after 6 hours of
HMP in DCD and DBD pancreata (P < 0.05). The absolute increase in amylase content after HMPwas higher than after SCS in the DCD group
(P < 0.05). C, D, Lipase content increased significantly after 6 hours of HMP in DCD and DBD pancreata (P < 0.05). In the DCD group, the ab-
solute increase in lipase was higher after HMP compared to SCS (P < 0.01). E, F, LDH increased significantly after 6 hours of HMP in both
groups (P < 0.05). The absolute increase in LDH after preservation did not differ between the 4 groups. Results are shown asmedian and IQR.
© 2018 Wolters Kluwer Leemkuil et al 7We suggest therefore thatHMPmight help to increase the do-
nor pool by improving the quality of pancreas grafts.
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